Precision appoints John Hubbard, PhD, as Board of Directors Chair
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
The business serves the healthcare and laboratory sectors on the west coast of the United States.
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
The new sterile filling line meets cGMP aseptic filling regulatory requirements
New manufacturing facility dedicated to the production of active pharmaceutical ingredients (APIs) and high potency active pharmaceutical ingredients (HPAPIs)
The investment enhances Lonza’s capabilities and flexibility to support both clinical and commercial supply and will play a key role in meeting the growing market demand for bioconjugates
Qure.ai is scaling-up the integration of its AI-powered chest x-ray interpretation tool that can benefit early and easy detection of lung diseases including lung cancer.
Subscribe To Our Newsletter & Stay Updated